Neurocrine Bioscience buy Royal Bank of Canada
Start price
31.07.25
/
50%
€112.45
Target price
31.07.26
€125.97
Performance (%)
9.43%
Price
09.09.25
€123.05
Summary
This prediction is currently active. With a performance of 9.43%, the BUY prediction by Royal_Bank_of_Canada for Neurocrine Bioscience is trending in the right direction. This prediction currently runs until 31.07.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 0.985% | 0.985% |
| iShares Core DAX® | 0.705% | -1.819% |
| iShares Nasdaq 100 | 2.046% | 0.465% |
| iShares Nikkei 225® | 3.676% | 2.282% |
| iShares S&P 500 | 0.996% | 1.498% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target lowered by analysts at Royal Bank Of Canada from $146.00 to $144.00. They now have an "outperform" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€123.05
05.09.25
05.09.25
€127.74
05.09.26
05.09.26
0.00%
09.09.25
09.09.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€108.85
02.06.25
02.06.25
€127.53
02.06.26
02.06.26
13.05%
09.09.25
09.09.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.90
06.05.25
06.05.25
€128.38
06.05.26
06.05.26
16.19%
09.09.25
09.09.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€83.38
14.04.25
14.04.25
€120.31
14.04.26
14.04.26
47.58%
09.09.25
09.09.25